Cargando…
The efficacy of dexmedetomidine for the prevention of catheter-related bladder discomfort: A systematic review and meta-analysis
BACKGROUND: The effective therapy to reduce postoperative catheter-related bladder discomfort (CRBD) remained unknown. OBJECTIVE: We attempted to manage the systematic review and a meta-analysis to clarify the efficacy of dexmedetomidine (DEX) in potential prevention on CRBD. METHODS: We performed t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718236/ https://www.ncbi.nlm.nih.gov/pubmed/34967355 http://dx.doi.org/10.1097/MD.0000000000028217 |
_version_ | 1784624681149530112 |
---|---|
author | Lu, Jia Yang, Xiamin Zhang, Jie Huang, Yuelong |
author_facet | Lu, Jia Yang, Xiamin Zhang, Jie Huang, Yuelong |
author_sort | Lu, Jia |
collection | PubMed |
description | BACKGROUND: The effective therapy to reduce postoperative catheter-related bladder discomfort (CRBD) remained unknown. OBJECTIVE: We attempted to manage the systematic review and a meta-analysis to clarify the efficacy of dexmedetomidine (DEX) in potential prevention on CRBD. METHODS: We performed the meta-analysis on randomized clinical trials (RCTs), and searched the databases from Web of Sciences, Embase and referred Cochrane Library published from October 2016 to September 2020. Data extraction was carefully conducted by 2 authors, respectively. Meta-analysis that was applied synthetically concerns the incidence and severity of CRBD and the treatment effect of DEX on CRBD. RESULTS: We acquired 5 RCTs with interventions of DEX on CRBD. Meta-analysis showed DEX has significantly reduced the incidence and severity of CRBD compared with control at 0 hour (risk ratios [RR] = 0.40, 95% CI = 0.53–0.29, P < .01), 1 hour (RR = 0.44, 95% CI = 0.34–0.57, P < .01), and 2 hours (RR = 0.43, 95% CI = 0.32–0.58, P < .01) and 6 hours (RR = 0.43, 95% CI = 0.29–0.63, P < .01). DEX was also associated with lower incidence of moderate to severe CRBD at 0, 1, and 6 hours after surgery. There were no significant differences in adverse events other than bradycardia, hypotension, and hypertension. CONCLUSION: The 5 RCTs showed great effectiveness in reducing the incidence and severity of the early and later postoperative CRBD. Meta-analysis showed that DEX interventions were useful in preventing the early and later postoperative CRBD without significant side effects. |
format | Online Article Text |
id | pubmed-8718236 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-87182362022-01-03 The efficacy of dexmedetomidine for the prevention of catheter-related bladder discomfort: A systematic review and meta-analysis Lu, Jia Yang, Xiamin Zhang, Jie Huang, Yuelong Medicine (Baltimore) 3300 BACKGROUND: The effective therapy to reduce postoperative catheter-related bladder discomfort (CRBD) remained unknown. OBJECTIVE: We attempted to manage the systematic review and a meta-analysis to clarify the efficacy of dexmedetomidine (DEX) in potential prevention on CRBD. METHODS: We performed the meta-analysis on randomized clinical trials (RCTs), and searched the databases from Web of Sciences, Embase and referred Cochrane Library published from October 2016 to September 2020. Data extraction was carefully conducted by 2 authors, respectively. Meta-analysis that was applied synthetically concerns the incidence and severity of CRBD and the treatment effect of DEX on CRBD. RESULTS: We acquired 5 RCTs with interventions of DEX on CRBD. Meta-analysis showed DEX has significantly reduced the incidence and severity of CRBD compared with control at 0 hour (risk ratios [RR] = 0.40, 95% CI = 0.53–0.29, P < .01), 1 hour (RR = 0.44, 95% CI = 0.34–0.57, P < .01), and 2 hours (RR = 0.43, 95% CI = 0.32–0.58, P < .01) and 6 hours (RR = 0.43, 95% CI = 0.29–0.63, P < .01). DEX was also associated with lower incidence of moderate to severe CRBD at 0, 1, and 6 hours after surgery. There were no significant differences in adverse events other than bradycardia, hypotension, and hypertension. CONCLUSION: The 5 RCTs showed great effectiveness in reducing the incidence and severity of the early and later postoperative CRBD. Meta-analysis showed that DEX interventions were useful in preventing the early and later postoperative CRBD without significant side effects. Lippincott Williams & Wilkins 2021-12-30 /pmc/articles/PMC8718236/ /pubmed/34967355 http://dx.doi.org/10.1097/MD.0000000000028217 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | 3300 Lu, Jia Yang, Xiamin Zhang, Jie Huang, Yuelong The efficacy of dexmedetomidine for the prevention of catheter-related bladder discomfort: A systematic review and meta-analysis |
title | The efficacy of dexmedetomidine for the prevention of catheter-related bladder discomfort: A systematic review and meta-analysis |
title_full | The efficacy of dexmedetomidine for the prevention of catheter-related bladder discomfort: A systematic review and meta-analysis |
title_fullStr | The efficacy of dexmedetomidine for the prevention of catheter-related bladder discomfort: A systematic review and meta-analysis |
title_full_unstemmed | The efficacy of dexmedetomidine for the prevention of catheter-related bladder discomfort: A systematic review and meta-analysis |
title_short | The efficacy of dexmedetomidine for the prevention of catheter-related bladder discomfort: A systematic review and meta-analysis |
title_sort | efficacy of dexmedetomidine for the prevention of catheter-related bladder discomfort: a systematic review and meta-analysis |
topic | 3300 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718236/ https://www.ncbi.nlm.nih.gov/pubmed/34967355 http://dx.doi.org/10.1097/MD.0000000000028217 |
work_keys_str_mv | AT lujia theefficacyofdexmedetomidineforthepreventionofcatheterrelatedbladderdiscomfortasystematicreviewandmetaanalysis AT yangxiamin theefficacyofdexmedetomidineforthepreventionofcatheterrelatedbladderdiscomfortasystematicreviewandmetaanalysis AT zhangjie theefficacyofdexmedetomidineforthepreventionofcatheterrelatedbladderdiscomfortasystematicreviewandmetaanalysis AT huangyuelong theefficacyofdexmedetomidineforthepreventionofcatheterrelatedbladderdiscomfortasystematicreviewandmetaanalysis AT lujia efficacyofdexmedetomidineforthepreventionofcatheterrelatedbladderdiscomfortasystematicreviewandmetaanalysis AT yangxiamin efficacyofdexmedetomidineforthepreventionofcatheterrelatedbladderdiscomfortasystematicreviewandmetaanalysis AT zhangjie efficacyofdexmedetomidineforthepreventionofcatheterrelatedbladderdiscomfortasystematicreviewandmetaanalysis AT huangyuelong efficacyofdexmedetomidineforthepreventionofcatheterrelatedbladderdiscomfortasystematicreviewandmetaanalysis |